HSE - PCRS

Application Details

HSE Application ID

HSE100067

HTA Number

25054

HTA Link

Drug

aflibercept

Brand

Eylea®

Applicant

Bayer Limited

Indication Applied For

Indicated in adults for the treatment of neovascular (wet) age-related macular degeneration (nAMD).

Application Date

22/08/2025

Marketing Authorisation Date

22/11/2012

Application Status

HSE Drugs Group Review Pending

18/12/2025

Proposal from Applicant Under Review

05/12/2025

Awaiting Proposal from Applicant

06/11/2025

Applicant Meeting Held with CPU

06/11/2025

Rapid Review Completed

19/09/2025

Rapid Review Commissioned

22/08/2025

Pricing and Reimbursement Application Complete

22/08/2025